Quantitative evaluation of123I-FP-CIT SPECT: Validation of a semiautomated method;Evaluación cuantitativa del SPET con123I-FP-CIT: Validación de un método semiautomático

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 4, 2005, Pages 244-249

  Lorenzo I Bosquet, C ^a   Cuberas Borros G ^a   Rodríguez, F Miquel ^a   Caresia, P ^a   Aguade Bruix S ^a   Castell Conesa, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Dopamine transporters; Parkinsonism; ROI; SPET; 123I FP CIT

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG INDUCED PARKINSONISM; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MALE; OCCIPITAL CORTEX; PARKINSON DISEASE; PARKINSONISM; PSYCHOGENIC PARKINSONISM; PUTAMEN; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 23044487634     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076642     Document Type: Article

References (17)

1. Benamer HTS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000;15:503-10.
2. Lorenzo Bosquet C, Miquel Rodríguez, F, Roca Bielsa I, Milà M, Aguadé Bruix S y Castell Conesa J. Contribución de la SPECT cerebral de transportadores de dopamina en el diagnóstico diferencial de los parkinsonismos. Med Clin (Barc). 2004;122:325-8.
3. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus J, Wetter C, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep. 2003;26:507-12.
4. Berendse H, Booij J, Francot C, Bergmans P, Hijman R, Stoof J, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol. 2001;50:34-41.
5. 123I]IPJ SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med. 2003;30:306-11.
6. 123I]IPT SPET in obsessive-compulsive disorder. Eur J Nucl Med Mol Imaging. 2003;30:1637-43.
7. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745-52.
8. Martí Massó JF, Poza JJ. Parkinsonismo inducido o agravado por fármacos: Características clínicas y evolución histórica de los fármacos implicados. Neurología. 1996;11:10-5.
9. Tolosa E, Coelho M, Gallardo. DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord. 2003;18:S28-S33.
10. Matsui T, Hirano A, editors. An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin; 1978.
11. 123I]β-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord. 2000;15:1158-67.
12. Walker Z, Costa D, Walker R, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:134-40.
13. Kim Y, Ichise M, Ballinger J, Vines D, Erami S, Tatschida T, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord. 2002;17:303-12.
14. Booij J, Habraken J, Bergmans P, Tissingh G, Winogrodzka A, Wolters E, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med. 1998;39:1879-84.
15. Løkkegaard A, Werdelin L, Friberg L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med. 2002;29:1623-29.
16. Weng Y, Yen T, Chen M, Kao P, Tzen K, Chen R, et al. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. J Nucl Med. 2004;45:393-401.
17. 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692-8.